Skip to content

Clinical trials

Withdrawn Phase 1/2 Brain Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Neoplasms Phase: Phase 1/2 Status: Withdrawn Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20132
20141
20151
20181
20191
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Barbara Ann Karmanos Cancer Institute1
Darell Bigner1
Endeavor Health1
Fox Chase Cancer Center1
M.D. Anderson Cancer Center1
Masonic Cancer Center, University of Minnesota1
National Cancer Institute (NCI)1
OHSU Knight Cancer Institute1
Reva Basho1
University of Arizona1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Neoplasms10
Glioblastoma4
Breast Neoplasms3
Glioma3
Gliosarcoma3
Central Nervous System Neoplasms2
Melanoma2
Astrocytoma1
Central Nervous System Diseases1
Drug-Related Side Effects and Adverse Reactions1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.